Literature DB >> 8382926

Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.

M H Godfried1, T van der Poll, J Jansen, J A Romijin, J K Schattenkerk, E Endert, S J van Deventer, H P Sauerwein.   

Abstract

OBJECTIVE: To assess the value of concentrations of soluble receptors for tumour necrosis factor (sTNFR) as markers for disease progression in HIV infection.
DESIGN: We measured concentrations of sTNFR in the serum of 32 HIV-infected male patients in various stages of disease and in 12 healthy male control subjects. Correlations between the levels of sTNFR and CD4+ lymphocyte counts were calculated.
RESULTS: Serum levels of sTNFR p55 and p75 were elevated in parallel with severity of clinical stage. sTNFR p55 levels were higher at later stages of HIV infection (Centers for Disease Control stage IV) with or without concurrent illness, whereas sTNFR p75 was already elevated in asymptomatic carriers, compared with controls. There was an inverse correlation between sTNFR concentrations and CD4+ lymphocyte counts.
CONCLUSIONS: Our results suggest that sTNFR concentrations could be potential markers for disease progression in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382926

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  18 in total

1.  CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.

Authors:  A Stronkhorst; S Radema; S L Yong; H Bijl; I J ten Berge; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.

Authors:  F Ajello; R La Licata; M Lodato; F Vitale; F Bonura; R Valenti; M Bruno; N Romano
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

3.  Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.

Authors:  M Weiss; M Martignoni; T Petropoulou; B Sölder; B H Belohradsky
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

4.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania.

Authors:  Saurabh Mehta; Ferdinand M Mugusi; Donna Spiegelman; Eduardo Villamor; Julia L Finkelstein; Ellen Hertzmark; Edward L Giovannucci; Gernard I Msamanga; Wafaie W Fawzi
Journal:  AIDS Patient Care STDS       Date:  2011-09-14       Impact factor: 5.078

6.  High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients.

Authors:  D Hober; S Benyoucef; A S Delannoy; D de Groote; F Ajana; Y Mouton; P Wattré
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

10.  C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting.

Authors:  Paul K Drain; Roland Kupka; Gernard I Msamanga; Willy Urassa; Ferdinand Mugusi; Wafaie W Fawzi
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.